it is not looking good - with the way things are going the response to the FDA on NUVARING will be sometime before end of year.
assuming that we follow the same timeframe as the previous response, FDA will provide update 10months after (last FDA response was done Dec2019).
so if we are to follow same timeframe as last year, the approval for Nuvaring may well be October 2021 - by then who knows how many other generic approval has gone through.
Ann: Mayne Pharma provides update on Women's Health pipeline, page-31
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |